KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Debt Ratio (2016 - 2025)

West Pharmaceutical Services' Debt Ratio history spans 17 years, with the latest figure at 0.05 for Q3 2025.

  • For Q3 2025, Debt Ratio fell 10.45% year-over-year to 0.05; the TTM value through Sep 2025 reached 0.05, down 10.45%, while the annual FY2024 figure was 0.06, 192.51% up from the prior year.
  • Debt Ratio for Q3 2025 was 0.05 at West Pharmaceutical Services, down from 0.05 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.09 in Q1 2021 and bottomed at 0.02 in Q4 2023.
  • The 5-year median for Debt Ratio is 0.06 (2025), against an average of 0.06.
  • The largest annual shift saw Debt Ratio tumbled 66.74% in 2023 before it surged 192.51% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 0.08 in 2021, then dropped by 25.14% to 0.06 in 2022, then plummeted by 66.74% to 0.02 in 2023, then surged by 192.51% to 0.06 in 2024, then decreased by 11.22% to 0.05 in 2025.
  • Per Business Quant, the three most recent readings for WST's Debt Ratio are 0.05 (Q3 2025), 0.05 (Q2 2025), and 0.06 (Q1 2025).